Sanofi (SNY) Intangibles (2009 - 2026)

Sanofi has disclosed Intangibles across 18 years of filings, most recently posting $30.6 billion for Q2 2026.

• In Q2 2026, Intangibles rose 32.48% year-over-year to $30.6 billion; the TTM figure through Jun 2026 stood at $30.6 billion (up 32.48% YoY), while the FY2025 annual figure was $30.6 billion, up 24.81% from the prior year.
• Intangibles came in at $30.6 billion for Q2 2026 at Sanofi, roughly flat from $30.6 billion in the prior quarter.
• In the past five years, Intangibles ranged from a high of $30.6 billion in Q2 2026 to a low of $22.1 billion in Q4 2022.
• Average Intangibles over 5 years is $26.2 billion, with a median of $26.2 billion recorded in 2023.
• Year-over-year, Intangibles retreated 19.42% in 2025 and jumped 32.48% in 2026.
• Over 5 years, Intangibles stood at $22.1 billion in 2022, then advanced by 18.51% to $26.2 billion in 2023, then slipped by 7.58% to $24.2 billion in 2024, then rose by 26.42% to $30.6 billion in 2025, then climbed by 0.23% to $30.6 billion in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $30.6 billion in Q2 2026, $30.6 billion in Q4 2025, and $23.1 billion in Q2 2025.